USFDA approval and continuous manufacturing adoption mark breakthrough year for STEER World in pharma Read more
Alembic Pharmaceuticals gets USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004% Read more
USFDA grants Orphan Drug Designation (ODD) to Zydus’ Desidustat for treatment of beta-thalassemia Read more